rs104893917
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PP2PP3_StrongPP5
The NM_000112.4(SLC26A2):c.764G>A(p.Gly255Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,614,004 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G255G) has been classified as Likely benign.
Frequency
Consequence
NM_000112.4 missense
Scores
Clinical Significance
Conservation
Publications
- achondrogenesis type IBInheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, G2P, ClinGen
- atelosteogenesis type IIInheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen, Ambry Genetics
- diastrophic dysplasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet
- multiple epiphyseal dysplasiaInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- multiple epiphyseal dysplasia type 4Inheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461838Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727226 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74332 show subpopulations
ClinVar
Submissions by phenotype
Atelosteogenesis type II Pathogenic:1
- -
Osteochondrodysplasia Pathogenic:1
Variant summary: SLC26A2 c.764G>A (p.Gly255Glu) results in a non-conservative amino acid change to a highly conserved residue (HGMD) located in the SLC26A/SulP transporter domain (IPR011547) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251356 control chromosomes. c.764G>A has been reported in the literature in an individual affected with Atelosteogenesis type II (Hastbacka_1996), and they were repoted as compound heterozygous with a variant that one ClinVar submitter has classified as pathogenic. These data suggest the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, showing <10% of normal DTDST-mediated sulfate uptake in Xenopus oocytes injected with cRNA containing the variant. Two submitters have provided clinical-significance assessments for this variant to ClinVar after 2014, and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Multiple epiphyseal dysplasia type 4 Uncertain:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
Diastrophic dysplasia;C0265274:Achondrogenesis, type IB;C1847593:Multiple epiphyseal dysplasia type 4;C1850554:Atelosteogenesis type II Uncertain:1
This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 255 of the SLC26A2 protein (p.Gly255Glu). This variant is present in population databases (rs104893917, gnomAD 0.01%). This missense change has been observed in individual(s) with atelosteogenesis type II (PMID: 8571951). ClinVar contains an entry for this variant (Variation ID: 4090). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC26A2 protein function. Experimental studies have shown that this missense change affects SLC26A2 function (PMID: 11448940). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at